Form 8-K - Current report:
SEC Accession No. 0000950170-25-106540
Filing Date
2025-08-11
Accepted
2025-08-11 16:06:39
Documents
12
Period of Report
2025-08-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sepn-20250811.htm   iXBRL 8-K 45909
2 EX-99.1 sepn-ex99_1.htm EX-99.1 138317
3 GRAPHIC img205902741_0.jpg GRAPHIC 11854
  Complete submission text file 0000950170-25-106540.txt   321557

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT sepn-20250811.xsd EX-101.SCH 25994
14 EXTRACTED XBRL INSTANCE DOCUMENT sepn-20250811_htm.xml XML 4933
Mailing Address 250 EAST GRAND AVENUE, SUITE 65 SOUTH SAN FRANCISCO CA 94080
Business Address 250 EAST GRAND AVENUE, SUITE 65 SOUTH SAN FRANCISCO CA 94080 650-338-3533
Septerna, Inc. (Filer) CIK: 0001984086 (see all company filings)

EIN.: 843891440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42382 | Film No.: 251202028
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)